BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25818412)

  • 1. Systematic in vitro and in vivo study on porous silicon to improve the oral bioavailability of celecoxib.
    Riikonen J; Correia A; Kovalainen M; Näkki S; Lehtonen M; Leppänen J; Rantanen J; Xu W; Araújo F; Hirvonen J; Järvinen K; Santos HA; Lehto VP
    Biomaterials; 2015 Jun; 52():44-55. PubMed ID: 25818412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesoporous carbon with spherical pores as a carrier for celecoxib with needle-like crystallinity: improve dissolution rate and bioavailability.
    Zhu W; Zhao Q; Sun C; Zhang Z; Jiang T; Sun J; Li Y; Wang S
    Mater Sci Eng C Mater Biol Appl; 2014 Jun; 39():13-20. PubMed ID: 24863191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism for increasing the oral bioavailability of poorly water-soluble drugs using uniform mesoporous carbon spheres as a carrier.
    Wang T; Zhao P; Zhao Q; Wang B; Wang S
    Drug Deliv; 2016; 23(2):420-8. PubMed ID: 24870199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
    Kumar D; Sailaja Chirravuri SV; Shastri NR
    Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of microenvironmental pH of nanoparticles for enhanced solubility and oral bioavailability of poorly water-soluble celecoxib.
    Ran Woo M; Bak YW; Cheon S; Suk Kim J; Hun Ji S; Park S; Woo S; Oh Kim J; Giu Jin S; Choi HG
    Int J Pharm; 2024 Jun; 659():124179. PubMed ID: 38692498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel three-dimensional large-pore mesoporous carbon matrix as a potential nanovehicle for the fast release of the poorly water-soluble drug, celecoxib.
    Zhang Y; Wang H; Li C; Sun B; Wang Y; Wang S; Gao C
    Pharm Res; 2014 Apr; 31(4):1059-70. PubMed ID: 24287624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro and In Vivo Evaluation of Core-Shell Mesoporous Silica as a Promising Water-Insoluble Drug Delivery System: Improving the Dissolution Rate and Bioavailability of Celecoxib With Needle-Like Crystallinity.
    Han C; Zhang S; Huang H; Dong Y; Sui X; Jian B; Zhu W
    J Pharm Sci; 2019 Oct; 108(10):3225-3232. PubMed ID: 31226426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colon-targeted celecoxib-loaded Eudragit® S100-coated poly-ε-caprolactone microparticles: preparation, characterization and in vivo evaluation in rats.
    Ghorab DM; Amin MM; Khowessah OM; Tadros MI
    Drug Deliv; 2011; 18(7):523-35. PubMed ID: 21793779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New times, new trends for ethionamide: In vitro evaluation of drug-loaded thermally carbonized porous silicon microparticles.
    Vale N; Mäkilä E; Salonen J; Gomes P; Hirvonen J; Santos HA
    Eur J Pharm Biopharm; 2012 Jun; 81(2):314-23. PubMed ID: 22418076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole.
    Kinnari P; Mäkilä E; Heikkilä T; Salonen J; Hirvonen J; Santos HA
    Int J Pharm; 2011 Jul; 414(1-2):148-56. PubMed ID: 21601623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled Dissolution of Griseofulvin Solid Dispersions from Electrosprayed Enteric Polymer Micromatrix Particles: Physicochemical Characterization and in Vitro Evaluation.
    Roine J; Kaasalainen M; Peurla M; Correia A; Araújo F; Santos HA; Murtomaa M; Salonen J
    Mol Pharm; 2015 Jul; 12(7):2254-64. PubMed ID: 26035734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel celecoxib-loaded nanosuspension using a wet media milling process.
    Jeong SC; Kim DS; Jin SG; Youn YS; Oh KT; Li DX; Yong CS; Oh Kim J; Kim KS; Choi HG
    Pharmazie; 2018 Sep; 73(9):498-502. PubMed ID: 30223931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion of celecoxib into fibrous ordered mesoporous carbon for enhanced oral bioavailability and reduced gastric irritancy.
    Zhao P; Jiang H; Jiang T; Zhi Z; Wu C; Sun C; Zhang J; Wang S
    Eur J Pharm Sci; 2012 Apr; 45(5):639-47. PubMed ID: 22251657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of solid carriers in pharmaceutical performance of solid supersaturable SEDDS of celecoxib.
    Chavan RB; Modi SR; Bansal AK
    Int J Pharm; 2015 Nov; 495(1):374-384. PubMed ID: 26364711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
    Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
    Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
    Zhang Y; Zhi Z; Li X; Gao J; Song Y
    Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, characterization and in vitro studies of celecoxib-loaded poly(ortho ester) nanoparticles targeted for intraocular drug delivery.
    Palamoor M; Jablonski MM
    Colloids Surf B Biointerfaces; 2013 Dec; 112():474-82. PubMed ID: 24103464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles.
    Limnell T; Riikonen J; Salonen J; Kaukonen AM; Laitinen L; Hirvonen J; Lehto VP
    Int J Pharm; 2007 Oct; 343(1-2):141-7. PubMed ID: 17600644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability and Ocular Pharmacokinetics of Celecoxib-Loaded Nanoparticles Topical Ophthalmic Formulations.
    Ibrahim MM; Abd-Elgawad AH; Soliman OA; Jablonski MM
    J Pharm Sci; 2016 Dec; 105(12):3691-3701. PubMed ID: 27789031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation.
    Sayed E; Karavasili C; Ruparelia K; Haj-Ahmad R; Charalambopoulou G; Steriotis T; Giasafaki D; Cox P; Singh N; Giassafaki LN; Mpenekou A; Markopoulou CK; Vizirianakis IS; Chang MW; Fatouros DG; Ahmad Z
    J Control Release; 2018 May; 278():142-155. PubMed ID: 29605567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.